LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Etoposide | 10 | 70.05 | 770.25 | 716 | 10413 | 0.0688 | -0.0193 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 70.05 | 770.25 | 785 | 10413 | 0.0754 | 0.0051 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 72.27 | 770.25 | 748 | 10730 | 0.0697 | -0.0077 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 72.27 | 770.25 | 800 | 10730 | 0.0746 | 0.0100 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 74.50 | 770.25 | 728 | 10991 | 0.0662 | -0.0146 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 74.50 | 770.25 | 796 | 10991 | 0.0724 | 0.0086 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 76.75 | 770.25 | 719 | 11262 | 0.0638 | -0.0176 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 76.75 | 770.25 | 800 | 11262 | 0.0710 | 0.0098 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 78.98 | 770.25 | 717 | 11518 | 0.0622 | -0.0182 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 78.98 | 770.25 | 788 | 11518 | 0.0684 | 0.0059 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 81.20 | 770.25 | 711 | 11766 | 0.0604 | -0.0201 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 81.20 | 770.25 | 816 | 11766 | 0.0694 | 0.0148 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 83.42 | 770.25 | 711 | 12031 | 0.0591 | -0.0200 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 83.42 | 770.25 | 825 | 12031 | 0.0686 | 0.0175 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 85.64 | 770.25 | 683 | 12287 | 0.0556 | -0.0296 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 85.64 | 770.25 | 783 | 12287 | 0.0637 | 0.0041 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 87.86 | 770.25 | 709 | 12543 | 0.0565 | -0.0204 | MN20160304_L02 | F18 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 87.86 | 770.25 | 799 | 12543 | 0.0637 | 0.0091 | MN20160304_L02 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 3.21 | 770.25 | 812 | 904 | 0.8976 | 0.2555 | MN20160304_L02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 3.21 | 770.25 | 847 | 904 | 0.9363 | 0.5060 | MN20160304_L02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 5.44 | 770.25 | 915 | 1012 | 0.9035 | 0.5467 | MN20160304_L02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 5.44 | 770.25 | 955 | 1012 | 0.9430 | 0.7237 | MN20160304_L02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 7.66 | 770.25 | 993 | 1090 | 0.9110 | 0.6605 | MN20160304_L02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 7.66 | 770.25 | 1047 | 1090 | 0.9606 | 0.8456 | MN20160304_L02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 10.06 | 770.25 | 1085 | 1218 | 0.8904 | 0.6783 | MN20160304_L02 | G05 |